DK0527752T3 - Ekspression af Bordetella pertactinantigener i Pichia - Google Patents

Ekspression af Bordetella pertactinantigener i Pichia

Info

Publication number
DK0527752T3
DK0527752T3 DK91906598T DK91906598T DK0527752T3 DK 0527752 T3 DK0527752 T3 DK 0527752T3 DK 91906598 T DK91906598 T DK 91906598T DK 91906598 T DK91906598 T DK 91906598T DK 0527752 T3 DK0527752 T3 DK 0527752T3
Authority
DK
Denmark
Prior art keywords
pichia
expression
antigens
bordetella
pertactin antigens
Prior art date
Application number
DK91906598T
Other languages
English (en)
Inventor
Jeffrey John Langley Cou Clare
Michael Anthony Langle Romanos
Original Assignee
Medeva Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10673740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0527752(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Pharma Limited filed Critical Medeva Pharma Limited
Application granted granted Critical
Publication of DK0527752T3 publication Critical patent/DK0527752T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK91906598T 1990-04-02 1991-03-28 Ekspression af Bordetella pertactinantigener i Pichia DK0527752T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909007416A GB9007416D0 (en) 1990-04-02 1990-04-02 Expression of heterologous protein in yeast
PCT/GB1991/000487 WO1991015571A1 (en) 1990-04-02 1991-03-28 Expression of heterologous protein in yeast

Publications (1)

Publication Number Publication Date
DK0527752T3 true DK0527752T3 (da) 1999-11-01

Family

ID=10673740

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91906598T DK0527752T3 (da) 1990-04-02 1991-03-28 Ekspression af Bordetella pertactinantigener i Pichia

Country Status (12)

Country Link
EP (2) EP0905251A1 (da)
JP (1) JP3510624B2 (da)
AT (1) ATE180013T1 (da)
CA (1) CA2078858C (da)
DE (1) DE69131226T2 (da)
DK (1) DK0527752T3 (da)
ES (1) ES2133284T3 (da)
FI (1) FI104981B (da)
GB (1) GB9007416D0 (da)
GR (1) GR3030632T3 (da)
NO (1) NO310150B1 (da)
WO (1) WO1991015571A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) † 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
GB9106568D0 (en) * 1991-03-27 1991-05-15 Wellcome Found Recombinant antigen
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9402832D0 (en) * 1994-02-15 1994-04-06 Smith Kline Beecham Biolog S A Novel process
DK1035133T3 (da) 1999-02-17 2005-05-02 Pfizer Prod Inc Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons
DE60133734T2 (de) 2000-05-25 2009-05-14 Institut Pasteur Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
EP1174505A1 (en) * 2000-06-30 2002-01-23 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228948A (en) * 1988-05-13 1991-06-25 Phillips Petroleum Co Hbv particles containing s and pre-s 2 proteins and recombinant processes for their production in yeast cells

Also Published As

Publication number Publication date
FI924368A (fi) 1992-09-29
FI104981B (fi) 2000-05-15
JPH05505725A (ja) 1993-08-26
ES2133284T3 (es) 1999-09-16
WO1991015571A1 (en) 1991-10-17
NO923781L (no) 1992-09-29
EP0527752B1 (en) 1999-05-12
DE69131226T2 (de) 1999-09-23
EP0905251A1 (en) 1999-03-31
ATE180013T1 (de) 1999-05-15
FI924368A0 (fi) 1992-09-29
NO310150B1 (no) 2001-05-28
DE69131226D1 (de) 1999-06-17
GB9007416D0 (en) 1990-05-30
JP3510624B2 (ja) 2004-03-29
GR3030632T3 (en) 1999-10-29
CA2078858C (en) 2001-05-15
CA2078858A1 (en) 1991-10-03
NO923781D0 (no) 1992-09-29
EP0527752A1 (en) 1993-02-24

Similar Documents

Publication Publication Date Title
DK0527752T3 (da) Ekspression af Bordetella pertactinantigener i Pichia
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
DK187889D0 (da) Dna-forbindelser og klonende vektorer, der koder for det monoklonale antistof ks1/4, samt chimere antistoffer afledt af ks1/4 og rettet mod et humant adenocarcinoma-antigen
NO931480L (no) Myk torisk kontaktlinse
TW222000B (da)
KR930000403A (ko) 유리모재의 화염연마방법
DE59101043D1 (de) Verwendung von mit Oxyalkylenethergruppen modifizierten Epoxypolysiloxanen als härtbare Beschichtungsmittel.
DK0545511T3 (da) Fremgangsmåde til fremstilling af mono-N-substiuerede tetraazamakrocycler
ATE162553T1 (de) Monoklonale antikörper gegen hepatitis-c-virus
BE836390A (fr) Antigene de l'hepatite a.
DK230489D0 (da) Rekombinant-dna-vektorer, der koder for en 4ae-0-isovalerylacylase afledt af et carbomycin-biosyntesegen, betegnet care, til anvendelse i streptomyces og andre organismer
DK0442372T3 (da) Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays
DK0533153T3 (da) Lineære plasmider af Pichia pastoris og DNA-fragmenter deraf
BE847343A (fr) Antigene d'hepatite a,
DE69209868D1 (de) Verwendung von Isomeren von Mono- und bis(methylbenzyle)xylen als Wärmeübertragungflüssigkeit
DK0406628T3 (da) Monoklonalt antistof mod endothelin, hybridoma, der kan producere det, samt radioimmunoassay for endothelin under anvendelse af antistoffet
DK0649849T3 (da) Fremgangsmåde til fremstilling af cephalosporiner
DE59102602D1 (de) Stark vergrösserndes achromatisches Linsensystem.
DK0480418T3 (da) Billedaflæsningsanordning
JPS5382434A (en) Surface covered plastic spectacle lens
ES465091A1 (es) Procedimiento para la preparacion de fenilformamidinas.
DE69128095D1 (de) Azelluläre impfstoffe
JPS6454461A (en) Electrostatic charge image developing toner
DK0661541T3 (da) Fremgangsmåde til fremstilling af langtidsstabile klare sera
HRPK920279B1 (en) Masterbatch for pvc mass dyeing